The depletion of macrophages using either chemicals or genetic manipulation has shown to reduce blood pressure and improve endothelial function and cardiac and vascular remodeling in hypertensive animals [11, 30], but it is still unclear whether macrophages play a direct role in the impairment of vascular insulin action and insulin signaling in hypertensive or metabolic diseases. The gene discussed is INS; the disease is metabolic disease.